Discontinued ProductEthyl 3,4-dihydroxybenzylidenecyanoacetate (Cat. No. 0517) has been withdrawn from sale for commercial reasons.
Potent and selective inhibitor of 12- and 15-lipoxygenase.
|Storage||Desiccate at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
References are publications that support the biological activity of the product.
Cho et al (1991) Novel caffeic acid derivatives - extremely potent inhibitors of 12-lipoxygenase. J.Med.Chem. 34 1503 PMID: 2016727
Keywords: Ethyl 3,4-dihydroxybenzylidenecyanoacetate, Ethyl 3,4-dihydroxybenzylidenecyanoacetate supplier, Lipoxygenase, 0517, Tocris Bioscience
Citations for Ethyl 3,4-dihydroxybenzylidenecyanoacetate
Citations are publications that use Tocris products.
Currently there are no citations for Ethyl 3,4-dihydroxybenzylidenecyanoacetate.
Reviews for Ethyl 3,4-dihydroxybenzylidenecyanoacetate
There are currently no reviews for this product. Be the first to review Ethyl 3,4-dihydroxybenzylidenecyanoacetate and earn rewards!
Have you used Ethyl 3,4-dihydroxybenzylidenecyanoacetate?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and EuropeSubmit a Review
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.